2008
DOI: 10.1213/ane.0b013e3181770f95
|View full text |Cite
|
Sign up to set email alerts
|

A Dose-Ranging Study of Intraarticular Midazolam for Pain Relief After Knee Arthroscopy

Abstract: We conclude that when intraarticular midazolam was compared with placebo there was a reduction in pain after day-case arthroscopic knee surgery; however, this pain relief was of relatively short duration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 15 publications
0
17
1
Order By: Relevance
“…There were no statistically significant differences between groups for AUC (weighted average level) regarding pain at rest (0-24 h): 10 (1-23) vs. 13 (7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19) Regarding levels of dizziness, sedation and nausea, number of vomits, number of patients vomiting and consumption of ondansetron, there were no significant differences at any time points between groups.…”
Section: Secondary Outcomesmentioning
confidence: 89%
See 1 more Smart Citation
“…There were no statistically significant differences between groups for AUC (weighted average level) regarding pain at rest (0-24 h): 10 (1-23) vs. 13 (7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19) Regarding levels of dizziness, sedation and nausea, number of vomits, number of patients vomiting and consumption of ondansetron, there were no significant differences at any time points between groups.…”
Section: Secondary Outcomesmentioning
confidence: 89%
“…[14][15][16][17][18] We considered a 50% reduction (20 mm) to be of clinical relevance. With a type I error (α) of 5% and a power (1-β) of 90%, a sample size of 68 patients, 34 in each group, would be required.…”
Section: Sample Size Estimationmentioning
confidence: 99%
“…This review is supported by a study by the same author group that found only those with intense pain after arthroscopy had any benefit from intra-articular morphine (Rosseland et al, 1999). Other agents have been studied in with some success including midazolam (increased the time to first analgesia after surgery compared to placebo), clonidine (additive effect with bupivacaine compared to bupivacaine alone) and neostigmine (more effective when compared to morphine) (Batra et al, 2008, Tamosiunas et al, 2005, Yang et al, 1998. Unfortunately these agents have been studies in a very limited capacity and a clear conclusion in unable to be drawn as their effectiveness.…”
Section: Knee Arthroscopymentioning
confidence: 88%
“…Clinical studies have demonstrated an enhanced analgesic effect from midazolam when administered by the centroneuraxial route in combination with bupivacaine [24][25][26]. Batra et al [8] demonstrated that intra-articular administration of midazolam reduced postoperative pain after day-case arthroscopic knee surgery.…”
Section: Discussionmentioning
confidence: 99%
“…Midazolam reduces A-delta-and C-fiber-evoked activity [7]. Intra-articular administration of midazolam decreased postoperative pain after arthroscopic knee surgery [8]. Midazolam combined with bupivacaine improved analgesia quality when used in brachial plexus block [9,10].…”
Section: Introductionmentioning
confidence: 99%